What is the Purpose of this Study?
The purpose of this study is to evaluate whether non-ischemic heart preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation. Participants will be on the heart transplant waiting list. The XVIVO Heart Preservation System is an experimental device that keeps a donated heart preserved for longer periods than standard preservation before a transplant. It is used to keep donor hearts cold and oxygenated by pumping a solution through the heart to provide oxygen and nutrients.
The study will only involve an available and matching donor heart that meets extended criteria. Extended criteria hearts come from donors where the heart may not meet the typical criteria for transplant. The typical criteria for hearts used for transplant are outside of the body usually no more than 4 hours and tend to be from younger donors with limited risk factors.
Patients will retain the opportunity to accept a standard criteria donor heart outside of the study (i.e., remain on the waitlist). If an extended criteria donor heart becomes available and is matched, the patient may receive a transplant with a heart transported/preserved with the XVIVO Heart Preservation System (XHPS) if eligible for the study.
Eligibility
- 1. Age ≥18 years.
- 2. Signed informed consent form (ICF).
- 3. Listed for heart transplantation
Show more
- 1. Age ≥18 years.
- 2. Signed informed consent form (ICF).
- 3. Listed for heart transplantation
- 1. Previous solid organ or bone marrow transplantation.
- 2. Requires a multi-organ transplant.
- 3. Subject is enrolled and ongoing in another investigational pharmaceutical or medical device clinical trial (Exception: observational studies are permitted).
- 4. Subject is on mechanical circulatory support pre-transplant other than durable LVAD, Impella or intra-aortic balloon pump.
- 5. History of complex congenital heart disease ie: single ventricle physiology (Per Investigators discretion).
- 6. Subject on renal replacement therapy/dialysis.
- 7. Ventilator dependence (subject is intubated at time of transplant/unable to provide consent or re-affirmation of consent).
- 8. Sensitized subject is undergoing desensitization treatment.
- 1. Estimated Cross Clamp Time ≥ 4 hours, OR
- 2. Estimated Cross Clamp Time ≥ 2 hours, AND
- Any ONE or more of the following:
- * Age ≥ 50 years
- * LVEF 40-50% at time of provisional acceptance
- * Down-time ≥ 20 mins
- * Hypertrophy/Septal thickness \>12- ≤16mm
- * Angiographic luminal irregularities with no significant CAD, OR
- 3. Donation after Circulatory Death (DCD) donors.
- 1. Unstable hemodynamics requiring high-dose inotropic support.
- 2. Significantly abnormal coronary angiogram defined as CAD \> 50% stenosis of one or more vessels.
- 3. Moderate to severe cardiac valve pathology.
- 4. Investigator's clinical decision to exclude from trial.
- 5. Previous Sternotomy.
Show less
Where can I participate?
Beverly
More about this Clinical Trial
What is the full name of this clinical trial?
A Prospective, Multi-center, Single-Arm, Open-
label Study of Hearts Transplanted after Non-Ischemic Heart PRESERVation from Extended Donors